ALNY · Alnylam Pharmaceuticals, Inc.
$228.65
+1.53 (+0.67%)
At close · Aug 14
Market Cap
$30.60B
Shares
133.81M
Press releases and events scraped from the company's investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.
Past events
| Date | Event | Type |
|---|---|---|
| 2026-07-30 | Alnylam Pharmaceuticals Q2 2026 Earnings Conference Call | Earnings call |
| 2026-06-25 | RNAi Roundtable: ALN-6400, Targeting Plasminogen to Address Rare Bleeding Disorders | Event |
| 2026-06-09 | Goldman Sachs 47th Annual Global Healthcare Conference | Conference |
| 2026-05-13 | BofA Securities Healthcare Conference | Conference |
| 2026-04-30 | Earnings conference call (announced in 8-K) | Earnings call |
| 2026-02-12 | Earnings conference call (announced in 8-K) | Earnings call |
Source: https://investors.alnylam.com/
Key facts
CIK
1178670
CUSIP
02043Q107
13F (30d)
739 filings
705 filers
Visit website
Investor relations